Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer

Cancer

Volumn 119, Issue 1, 2013, Pages 226-232

  Monaco III, Edward A ^a   Faraji, Amir H ^a   Berkowitz, Oren ^a   Parry, Phillip V ^a   Hadelsberg, Uri ^a   Kano, Hideyuki ^a   Niranjan, Ajay ^a   Kondziolka, Douglas ^a   Lunsford, L Dade ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

brain metastasis; Gamma Knife; lung cancer; stereotactic radiosurgery; toxicity

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; COGNITIVE DEFECT; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; IMAGE ANALYSIS; LEUKOENCEPHALOPATHY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR VOLUME; WHITE MATTER INJURY;

ADULT; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84872767557     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27504     Document Type: Article

References (42)

1. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R,. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981; 7: 1633-1638.
2. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980; 6: 1-9.
3. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R,. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys. 1991; 20: 53-58.
4. Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ,. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys. 1995; 33: 339-348.
5. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N,. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev. 2006; 3: CD003869.
6. Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD,. Outcome predictors of Gamma Knife radiosurgery for renal cell carcinoma metastases. Neurosurgery. 2011; 69: 1232-1239.
7. Kondziolka D, Kano H, Harrison GL, et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg. 2011; 114: 792-800.
8. Liew DN, Kano H, Kondziolka D, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg. 2011; 114: 769-779.
9. Flannery T, Kano H, Niranjan A, et al. Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases. Int J Radiat Oncol Biol Phys. 2010; 76: 513-519.
10. Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD,. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer. 2008; 113: 2610-2614.
11. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD,. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg. 2002; 97: 1276-1281.
12. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC,. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999; 45: 427-434.
13. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD,. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006; 64: 898-903.
14. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006; 295: 2483-2491.
15. Burger PC, Mahley MS Jr, Dudka L, Vogel FS,. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979; 44: 1256-1272.
16. Hopewell JW,. Late radiation damage to the central nervous system: a radiobiological interpretation. Neuropathol Appl Neurobiol. 1979; 5: 329-343.
17. Tiller-Borcich JK, Fike JR, Phillips TL, Davis RL,. Pathology of delayed radiation brain damage: an experimental canine model. Radiat Res. 1987; 110: 161-172.
18. van der Kogel AJ,. The nervous system: radiobiology and experimental pathology. In:, Scherer E, Streffer C, Trott KR, eds. Radiopathology of Organs and Tissues. Berlin, Germany: Springer Verlag; 1991: 191-212.
19. Panagiotakos G, Alshamy G, Chan B, et al. Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One. 2007; 2 (7): e588.
20. Carmichael O, Schwarz C, Drucker D, et al. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol. 2010; 67: 1370-1378.
21. Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke. 1994; 25: 1109-1115.
22. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA,. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987; 149: 351-356.
23. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD,. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol. 2005; 28: 173-179.
24. Fujii O, Tsujino K, Soejima T, Yoden E, Ichimiya Y, Sugimura K,. White matter changes on magnetic resonance imaging following whole-brain radiotherapy for brain metastases. Radiat Med. 2006; 24: 345-350.
25. Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP,. Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol. 1987; 149: 165-171.
26. Szerlip N, Rutter C, Ram N, et al. Factors impacting volumetric white matter changes following whole brain radiation therapy. J Neurooncol. 2011; 103: 111-119.
27. Ahles TA, Saykin AJ,. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007; 7: 192-201.
28. Regine WF, Scott C, Murray K, Curran W,. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys. 2001; 51: 711-717.
29. Caveness WF,. Experimental observations: delayed necrosis in normal monkey brain. In:, Gilbert HA, Kagan AR, eds. Radiation Damage to the Nervous System: A Delayed Therapeutic Hazard. New York, NY: Raven; 1980: 1-38.
30. Denekamp J, Fowler JF,. Cell proliferation kinetics and radiation therapy. In:, Becker FF, ed. Cancer: A Comprehensive Treatise. New York, NY: Plenum; 1975: 101-137.
31. Groothuis DR, Vick N,. Radionecrosis of the central nervous system: the persective of the clinical neurologist and neuropathologist. In:, Gilbert HA, Kagan AR, eds. Radiation Damage to the Nervous System: A Delayed Therapeutic Hazard. New York, NY: Raven; 1980: 93-106.
32. Curnes JT, Laster DW, Ball MR, Moody DM, Witcofski RL,. MRI of radiation injury to the brain. AJR Am J Roentgenol. 1986; 147: 119-124.
33. Nieder C, Leicht A, Motaref B, Nestle U, Niewald M, Schnabel K,. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol. 1999; 22: 573-579.
34. Shibamoto Y, Baba F, Oda K, et al. Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys. 2008; 72: 1168-1173.
35. Conill C, Berenguer J, Vargas M, et al. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol. 2007; 9: 590-595.
36. O'sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS,. Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology. 2001; 57: 632-638.
37. Merchant TE, Kiehna EN, Li C, Xiong X, Mulhern RK,. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys. 2005; 63: 1546-1554.
38. Rutkowski S,. Current treatment approaches to early childhood medulloblastoma. Expert Rev Neurother. 2006; 6: 1211-1221.
39. DeAngelis LM, Currie VE, Kim JH, et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases. J Neurooncol. 1989; 7: 241-247.
40. Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007; 68: 1388-1395.
41. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009; 10: 1037-1044.
42. Nakaya K, Hori T, Izawa M, Yamamoto M,. Gamma knife radiosurgery for 10 or more brain metastases: Analysis of whole brain irradiation doses. Tokyo Joshi Ikadaugaku Zasshi. 2002; 72: 18-23.